One embodiment of the present invention provides novel functionally enhanced mesenchymal progenitor cells overexpressing epidermal growth factor receptor (EGF-R) in comparison with mesenchymal stem cells (MSCs), and downexpressing cluster differentiation 95 (CD95) in comparison with the MSCs.
展开▼